Status:
COMPLETED
Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
Rhode Island Hospital
Conditions:
Depressive Disorder, Major
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is develop and test a cognitive-behavioral intervention to prevent depression in methadone maintenance patients receiving medical treatment for hepatitis C.
Detailed Description
The purpose of this study is to develop a CBT-D intervention tailored to meet the needs of MMT patients undergoing antiviral treatment for hepatitis C. In the first phase of this project (Year 1), we ...
Eligibility Criteria
Inclusion
- Currently undergoing HCV treatment at RIH
- Enrolled in MMT for at least 6 months
Exclusion
- Current major depressive episode
- Current suicidality
- Currently taking antidepressant medication
- Received HCV treatment in past
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00218556
Start Date
January 1 2004
End Date
June 1 2008
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rhode Island Hospital
Providence, Rhode Island, United States, 02903